View AllPharmaBiotechMedical
20 June 2018
The CAT sets a clear framework for excessive and unfair prices in its Pfizer/Flynn judgment

The Competition Appeal Tribunal (CAT) recently gave its judgment in Pfizer and Flynn’s appeal of...

13 June 2018
Drafting leases for life sciences

Over the past decade, the UK life sciences sector has enjoyed rapid expansion, aided by...

8 June 2018
Driving immunotherapy forward: More than CAR-Ts

With two therapies already on the market and many more in the pipeline, CAR-T is...

14 May 2018
Depression Delayed: CMA’s paroxetine pay-for-delay case heads to Luxembourg

On 8 March 2018, the Competition Appeal Tribunal (CAT) gave an initial judgment in appeals brought by...

9 May 2018
The NHS gets on the bandwagon with CAR-T

Of interest to our UK readers will be the announcement by Simon Stevens, the chief...

9 May 2018
Can’t Stop the CAR-T

Despite it being only two months since our last review of the CAR-T world, the scientific and...

5 April 2018
We have our transition period for goods but what about the regulations? How the life sciences industry may be affected by Brexit

The European Commission published a Draft Withdrawal Agreement (the Agreement) on 19 March 2018. The Agreement...

7 March 2018
Side CAR-Ts

Big pharma’s interest in chimeric antigen receptor (CAR)-T therapies is clear:  companies such as Novartis...

20 February 2018
CAR-T rolls on

Over recent months, the cellular immunotherapy landscape has continued to develop apace.  Various new acquisitions...

16 February 2018
The competition law issues of the CRISPR patent pool

CRISPR-Cas9 is heralded as a revolutionary gene editing technology that is regularly hitting the headlines...

16 February 2018
Different types of value transfer in ‘reverse payment’ settlement agreements

In recent years, competition authorities and courts in the EU and the US have paid...

9 February 2018
Specific Mechanism applies to extended SPC period opines AG Tanchev

On 7 February 2018 Advocate General Tanchev delivered his opinion in Pfizer Ireland Pharmaceuticals v...